
TMPRSS6 - Wikipedia
Transmembrane protease, serine 6 (also known as matriptase-2) is an enzyme that in humans is encoded by the TMPRSS6 gene. [5] Based on twin studies, mutations in TMPRSS6 gene have a correlation with iron deficiency predisposition. [6] The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the ...
TMPRSS6 Gene - GeneCards | TMPS6 Protein | TMPS6 Antibody
2024年12月25日 · TMPRSS6 (Transmembrane Serine Protease 6) is a Protein Coding gene. Diseases associated with TMPRSS6 include Iron-Refractory Iron Deficiency Anemia and Microcytic Anemia. Among its related pathways are Extracellular matrix organization and Collagen chain trimerization.
TMPRSS6 gene - MedlinePlus
At least 40 mutations in the TMPRSS6 gene have been found to cause an inherited form of anemia called iron-refractory iron deficiency anemia. This condition is characterized by a shortage (deficiency) of iron in the bloodstream that is resistant (refractory) to treatment with iron.
TMPRSS6 as a Therapeutic Target for Disorders of ... - Springer
2023年1月23日 · TMPRSS6 functions as a negative regulator of the expression of the systemic iron-regulatory hormone hepcidin. Over the last decade and a half, growing understanding of TMPRSS6 biology and mechanism of action has enabled development of new therapeutic approaches for patients with diseases of erythropoiesis and iron homeostasis.
Transmembrane serine protease 6, a novel target for inhibition of ...
2024年1月13日 · In the present study, we found that Tmprss6 markedly inhibited mouse neuroblastoma N2a (neuro-2a) cell proliferation and tumor growth in nude mice. Tmprss6 inhibits Smad1/5/8 phosphorylation by...
TMPRSS6 transmembrane serine protease 6 [ (human)]
2025年1月4日 · TMPRSS6 mutations are associated with iron-refractory iron deficiency anemia. Article summarized the functional relevance of matriptase-2 in iron metabolism. TMPRSS6 mutation leads to overproduction of hepcidin and, in turn, to …
迈威生物TMPRSS6抗体9MW3011获FDA快速通道认定 - 知乎
2023年9月25日 · 9MW3011是迈威生物在美国 San Diego的创新研发中心自主研发的,属性为治疗用生物制品1类的抗TMPRSS6 单克隆抗体 。 该药物的靶点主要表达在肝细胞膜表面,通过 特异性结合 ,9MW3011可上调肝细胞表达 铁调素 (Hepcidin) 的水平,进而抑制铁元素的吸收和释放,减 …
TMPRSS6 as a Therapeutic Target for Disorders of ... - PubMed
TMPRSS6 functions as a negative regulator of the expression of the systemic iron-regulatory hormone hepcidin. Over the last decade and a half, growing understanding of TMPRSS6 biology and mechanism of action has enabled development of new therapeutic approaches for patients with diseases of erythropoiesis and iron homeostasis.ClinicalTrials.gov ...
铁调素及其相关调节药物的研究进展 - 国际输血及血液学杂志
铁调素由Hamp基因编码,其表达由BMP、STAT等多条信号通路调控,白细胞介素 (IL)-6、跨膜丝氨酸蛋白酶 (TMPRSS)6等信号分子亦在铁调素的调节中发挥重要作用。 笔者现就铁调素的分子结构、作用,以及目前针对铁调素、Hamp基因及其相关信号通路的调节药物的研究进展进行综述。 引用本文: 陈莹莹, 王丽红, 郝长来. 铁调素及其相关调节药物的研究进展 [J] . 国际输血及血液学杂志, 2019, 42 (1) : 85-89. DOI: 10.3760/cma.j.issn.1673-419X.2019.01.014. 版权归中华医学会所 …
TMPRSS6 - 百度百科
TMPRSS6是一种基因,变异后就会“沉默”,如果缺乏TMPRSS6 基因编码的蛋白质,人体内就会产生过多Hepcidin激素。 正常情况下,这种激素负责控制人体不要过量吸收铁。